首页 | 本学科首页   官方微博 | 高级检索  
     

川芎嗪抑制人视网膜母细胞瘤SO-RB50生长机制的研究
引用本文:陈朝,潘雪珂,余克明,庄菁. 川芎嗪抑制人视网膜母细胞瘤SO-RB50生长机制的研究[J]. 新医学, 2012, 43(6): 376-379
作者姓名:陈朝  潘雪珂  余克明  庄菁
作者单位:1. 中山大学中山眼科中心眼科学国家重点实验室,510060
2. 美国夏威夷马诺阿生物科学有限公司,96822
摘    要:目的:研究川芎嗪对人视网膜母细胞瘤(RB)SO-RB50细胞增殖的影响,并探讨其作用与趋化因子CXCR4表达水平之间的关系。方法:体外培养人SO-RB50细胞,经川芎嗪处理不同时间后,应用MTT法检测SO-RB50细胞的增殖抑制;采用荧光定量逆转录PCR和蛋白免疫印迹法分别从基因和蛋白质水平检测川芎嗪对SO-RB50细胞趋化因子受体CXCR4表达的影响,进而应用流式细胞仪检测SO-RB50细胞的细胞周期分布。结果:MTT结果显示川芎嗪对人SO-RB50细胞增殖有明显的抑制作用,与对照组比较差异具有统计学意义(P<0.01);细胞周期结果显示川芎嗪处理后的SO-RB50细胞G0/G1期增多,S期细胞减少,与对照组比较差异有统计学意义(P<0.01);通过荧光定量逆转录PCR及蛋白免疫印迹实验证明,川芎嗪能下调人SO-RB50细胞CXCR4的表达水平。结论:川芎嗪对人SO-RB50细胞的增殖有明显抑制作用,且能下调SO-RB50细胞中与肿瘤发生及生长密切相关的CXCR4表达水平。

关 键 词:川芎嗪  人视网膜母细胞瘤  细胞周期  CXCR4

Effects of tetramethylpyrazine on human retinoblastoma cell line SO-RB50 and its mechanisms
CHEN Zhao , PAN Xue-ke , YU Ke-ming , Joseph M. Kaminski , ZHUANG Jing. Effects of tetramethylpyrazine on human retinoblastoma cell line SO-RB50 and its mechanisms[J]. New Chinese Medicine, 2012, 43(6): 376-379
Authors:CHEN Zhao    PAN Xue-ke    YU Ke-ming    Joseph M. Kaminski    ZHUANG Jing
Affiliation:1.1 Department of State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center,Sun Yat-sen University,Guangzhou 510060,China;2 Manoa Biosciences Inc,Hawaii 96822,USA;
Abstract:Objective: To investigate the effect of tetrame-thylpyrazine(TMP) on cell proliferation,CXCR4 expression,cell cycle phase and apoptosis of human retinoblastoma cell line SO-RB50 and to elucidate its possible molecular mechanisms.Methods: SO-RB50 cells were treated with TMP for 48 hours or 72 hours.Methylthiazolyl tetrazolium assay was performed to test the inhibitory effect of TMP on cell proliferation.Quantitative Real-time(RT-PCR) and western blot were adopted to evaluate CXCR4 expression on SO-RB50 cells.Flow cytometry was used to detect the apoptosis and cell cycle of the SO-RB50 cell line.Results: MTT showed that TMP remarkably inhibited cell viability and growth of SO-RB50 cells(P0.01).RT-PCR and Western blot results showed that TMP down-regulated CXCR4 expression in SO-RB50 cells both at RNA and protein levels.Flow cytometry demonstrated that TMP increased the rate of G0/G1 of SO-RB50 cell cycle(P0.01).Conclusions: TMP can inhibit the viability and growth of human retinoblastoma SO-RB50 cell line.To our knowledge,this is the first study to reveal the mechanism of TMP treatment involving the inhibition of chemokine and CXCR4 expression in SO-RB50.
Keywords:Tetramethylpyrazine  SO-RB50  Cell cycle  CXCR4
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号